Stay updated on DECIDE Clinical Trial: Dapagliflozin vs. Standard Care

Sign up to get notified when there's something new on the DECIDE Clinical Trial: Dapagliflozin vs. Standard Care page.
Latest website image capture
Clouds background image

Latest updates to the DECIDE Clinical Trial: Dapagliflozin vs. Standard Care page

  1. Check
    5 days ago
    Change Detected
    Summary
    Site revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T11:11:50.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Page revision updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T19:21:40.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T18:12:50.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Status updated to Completed with new dates; the previous 'Active, not recruiting' designation was removed.
    Difference
    0.4%
    Check dated 2026-02-25T10:40:01.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Added Type 2 diabetes as a study topic and included a related topic link to MedlinePlus Genetics.
    Difference
    0.1%
    Check dated 2026-02-18T07:49:41.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    The update adds a new revision label (v3.4.2) and removes non-study topics and an older revision note, with no impact on the study details or user interactions on the page.
    Difference
    0.3%
    Check dated 2026-02-11T09:53:11.000Z thumbnail image

Stay in the know with updates to DECIDE Clinical Trial: Dapagliflozin vs. Standard Care

Enter your email address, and we'll notify you when there's something new on the DECIDE Clinical Trial: Dapagliflozin vs. Standard Care page.